Guangxi Tianshi

Guangxi Tianshi Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Nanning, China, that combines large-scale distribution with the manufacturing of niche biological and chemical products. As a key subsidiary of the China Meheco Group, the company is notably recognized for its expertise in developing and producing snake venom-derived hemostatic agents, such as Hemocoagulase for Injection. Its business operations also encompass an extensive GSP-certified logistics network that serves as a primary supplier for healthcare institutions in the Guangxi region. The company's portfolio spans multiple therapeutic areas, including anti-infectives, cardiovascular health, and Traditional Chinese Medicine (TCM). By integrating R&D in biochemical drugs with a robust commercial infrastructure, Guangxi Tianshi Pharmaceutical maintains a significant presence in both the regional distribution and specialized manufacturing sectors.